XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities:    
Net income (loss) $ (2,278,270) $ (7,597,328)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Change in unrealized (gain) loss on open commodity futures contracts (2,465,648) (514,567)
(Increase) decrease in receivable from General Partner 106,491 134,606
(Increase) decrease in dividends receivable 5,262 40,808
(Increase) decrease in interest receivable (4,561) 1,435
(Increase) decrease in prepaid other 634 (647)
(Increase) decrease in prepaid insurance (946) (6,693)
Increase (decrease) in General Partner management fees payable (139) (9,655)
Increase (decrease) in professional fees payable (24,045) (41,407)
Increase (decrease) in directors' fees payable (24) (38)
Net cash provided by (used in) operating activities (4,661,246) (7,993,486)
Cash Flows from Financing Activities:    
Addition of partnership shares 12,693,042 2,589,489
Redemption of partnership shares (9,610,135) (5,409,930)
Net cash provided by (used in) financing activities 3,082,907 (2,820,441)
Net Increase (Decrease) in Cash and Cash Equivalents (1,578,339) (10,813,927)
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 20,591,178 33,256,800
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 19,012,839 22,442,873
Components of Cash and Cash Equivalents, and Equity in Trading Account:    
Cash and cash equivalents 15,055,290 12,208,139
Equity in Trading Accounts:    
Cash and cash equivalents 3,957,549 10,234,734
Total Cash, Cash Equivalents and Equity in Trading Accounts $ 19,012,839 $ 22,442,873